a developer of technologies to treat cancers and infectious diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LMCCX | 32.14 | 0.33 | +1.04% |
Lord Abbett Mid Cap Stock C | |||
GICAX | 13.10 | N/A | N/A |
Goldman Sachs Intl Sm Cp Insghts A | |||
CVFYX | 14.77 | N/A | N/A |
Pioneer Disciplined Value Y | |||
USERX | 11.76 | -0.27 | -2.24% |
US Global Investors Gld & Prec Mtls | |||
FRCB | 0.02 | -0.01 | -33.33% |
First Republic Bank (San Francisco, California) |
A.I.dvisor indicates that over the last year, AGEN has been closely correlated with RNAC. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then RNAC could also see price increases.
Ticker / NAME | Correlation To AGEN | 1D Price Change % | ||
---|---|---|---|---|
AGEN | 100% | -2.61% | ||
RNAC - AGEN | 93% Closely correlated | +1.04% | ||
CRPOF - AGEN | 93% Closely correlated | N/A | ||
SNPX - AGEN | 91% Closely correlated | +0.49% | ||
ALLR - AGEN | 87% Closely correlated | +8.51% | ||
NRXP - AGEN | 83% Closely correlated | -3.70% | ||
More |